14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:JUNO
Delisted

Juno Therapeutics Fund Price (Quote)

$86.96
+0 (+0%)
At Close: Mar 28, 2018

Range Low Price High Price Comment
30 days $141.16 $183.01 Wednesday, 28th Mar 2018 JUNO stock ended at $86.96. During the day the stock fluctuated 0% from a day low at $86.96 to a day high of $86.96.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Juno Therapeutics prices

Date Open High Low Close Volume
Mar 28, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 27, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 26, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 23, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 22, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 21, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 20, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 19, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 16, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 15, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 14, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 13, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 12, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 09, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 08, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 07, 2018 $86.96 $86.96 $86.96 $86.96 0
Mar 06, 2018 $86.96 $86.96 $86.96 $86.96 2
Mar 05, 2018 $86.97 $87.01 $86.90 $86.96 3 696 100
Mar 02, 2018 $86.81 $86.93 $86.80 $86.87 3 009 894
Mar 01, 2018 $86.77 $86.91 $86.73 $86.75 2 379 980
Feb 28, 2018 $86.67 $86.83 $86.65 $86.75 1 049 300
Feb 27, 2018 $86.60 $86.80 $86.60 $86.63 2 357 553
Feb 26, 2018 $86.62 $86.63 $86.56 $86.60 5 281 223
Feb 23, 2018 $86.59 $86.59 $86.55 $86.58 4 289 808
Feb 22, 2018 $86.65 $86.68 $86.56 $86.56 5 431 546
Click to get the best stock tips daily for free!

About Juno Therapeutics

Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells. Its clinical stage CD19 product candidates include JCAR015 that is in Phase II clinical trials for adult patients with relapsed/refractory B cel... JUNO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT